VANCOUVER, Dec. 10 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced
today that in conjunction with its annual evaluation process it has
issued a combined total of 150,000 incentive stock options to six
directors of the Company exercisable at $1.38 for a period of five
years pursuant to its Stock Option Plan. Its Stock Option Plan has been
approved by Shareholders and the TSX Venture Exchange.
About CRH Medical Corporation:
CRH Medical Corporation is a value added resource to the
Gastroenterologist community, providing the CRH O'Regan System, as well
as delivering related, clinical, marketing and operational support
directly to its partner physicians. CRH utilizes its web based platform
to connect doctors with patients as well as educating its ever
increasing install base of physicians. CRH's single use, disposable,
hemorrhoid technology is safe and highly effective in treating
hemorrhoid grades I - IV. The Company's goal is to establish the CRH
O'Regan System as the standard for hemorrhoid treatment.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this
SOURCE CRH Medical Corporation
For further information: For further information:
Dean Linden, Corporate Communications, CRH Medical Corporation at 604.633.1440 or email@example.com. Additional information may also be found by visiting the Company's website at www.crhmedcorp.com or the SEDAR website at www.sedar.com.